A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Clinical trial NCT06615050 · RECRUITING

Trial details

NCT number: NCT06615050
Sponsor: Incyte Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Graft-versus-host Disease (GVHD)

Start date: 2025-04-02
Primary completion: 2031-01-17
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.